生态毒理学数据在国家基本药物清单中的潜在作用:横截面分析
Camila Heredia1, Aine Workentin1, Gillian Parker2
1MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1T8, Canada.
概括
制药污染带来了环境风险. 基本药物清单 (EML) 可以帮助识别高风险药物并促进可持续的药物选择,尽管生态毒理学数据有限.
科学领域:
- 环境科学 环境科学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 制药产品在其整个生命周期中对环境产生影响,导致空气,水和土壤污染.
- 制药污染是一个公认的全球性问题,需要环境风险评估和可持续实践.
研究的目的:
- 评估在必需药物清单 (EML) 上列出的药物的环境风险.
- 识别具有高生态毒性药物并评估其在国家EML中的存在.
- 探索EMLs在减轻制药污染方面的潜力.
主要方法:
- 来自158个国家的基本药物清单 (EML) 进行了审查.
- 检查了药物的生态毒理学数据,重点关注生物积累,持久性和毒性.
- 交叉引用高风险药物,并将其纳入EML和分析的替代品.
主要成果:
- 五种药物 (西普罗夫洛克萨,乙乙醇,勒沃诺格斯特勒,布洛芬,塞特拉林) 被确定为高度持久和有毒的药物.
- 这五种药物被列入2023年世界卫生组织 (WHO) 模型清单.
- 在94.3%的国家EML中发现了西普罗素,突出显示了生态毒药物的广泛含量.
结论:
- 有限的生态毒理学数据阻碍了对药品进行全面的环境风险评估.
- 可以利用EML来提高对制药污染的认识和数据.
- 将环境标准纳入EML可以促进可持续的药物选择和监管方法.
更多相关视频
08:14Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
Published on: April 28, 2023
254
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
13.8K
相关概念视频
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Pharmacovigilance
739
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
739
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Drug Classes and Categories
1.8K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.8K
Drug Control Governance: Regulatory Bodies and Their Impact
119
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
119
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
